VitalHub Corp. Announces Results of Annual General Meeting of Shareholders
TORONTO, June 29, 2023 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) today reported a...
TORONTO, June 29, 2023 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) today reported a...
Integration expansion enables streamlined payment options for Nextech clientsTAMPA, Fla., June 29, 2023 (GLOBE NEWSWIRE) -- Nextech, a complete healthcare...
Distinguished Healthcare Leader Adam Boehler to Join BoardIncoming CEO Parth Mehrotra to Join BoardWill Sherrill Resigns from BoardARLINGTON, Va,, June...
BURLINGTON, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development...
CINCINNATI, Ohio, June 28, 2023 (GLOBE NEWSWIRE) -- Blue Water Biotech, Inc. (“Blue Water” or the “Company”) (Nasdaq: BWV), a...
MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares ZUG, Switzerland, June 28, 2023...
Dengue is a mosquito-borne viral infection listed by WHO as top 10 threat for global health The government grant is...
SriniVas R. Sadda, MD SriniVas R. Sadda, MD, is the Director, Artificial Intelligence & Imaging Research, Doheny Eye Institute and...
ART26.12, a Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor, Shows Favorable Results in Studies for Chemotherapy-Induced Neuropathy and Diabetic...
SOUTH SAN FRANCISCO, Calif., June 27, 2023 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (Nasdaq: HARP), a clinical-stage immuno-oncology company developing...
AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease Ongoing Phase 1b/2 ABATE...
ART12.11, a novel and patented cocrystal of CBD reverses the impact of chronic stress on outcomes of anxiety, depression, sociability and...
Press Release No. 5 / 2023 Data shows nearly 19% weight loss in people with overweight or obesity in Boehringer...
MUNICH, Germany, June 21, 2023 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC” or the “company”), a global clinical-stage biopharmaceutical company,...
WAKEFIELD, MA, June 21, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical...
The company is one of the first in the U.S. with complete end-to-end gene therapy capabilities in Massachusetts, from research...
Teladoc Health and Humana Veteran Will Lead the Company’s Technology, Product Development, and Data Analytics Functions Julia Zhang, Chief Technology...
MISSISSAUGA, Ontario, June 20, 2023 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce...
Study between nasal and oral metoclopramide selected by Digestive Disease Week (DDW) 2023 faculty for plenary presentationSOLANA BEACH, Calif., June...
Balance Sheet Initiatives Bolster Financial Strength as Company Scales Business Towards Cash Flow Break-EvenSAN FRANCISCO, June 14, 2023 (GLOBE NEWSWIRE)...